The global problem of antibiotic resistance

Area of Science:

• Microbiology
• Genetics
• Pharmacology

Background:

• Human pathogens are increasingly resistant to common antibiotics, driven by overuse of antimicrobial products.
• Pathogenic bacteria possess sophisticated genetic systems for evolving antibiotic resistance mechanisms.
• The development of new antimicrobial agents has lagged significantly behind the rapid evolution of resistance.

Purpose of the Study:

• To highlight the growing challenge of antibiotic resistance in both hospital and community-acquired infections.
• To discuss the complex genetic mechanisms underlying multidrug resistance (MDR) in bacterial pathogens.
• To emphasize the urgent need for novel antimicrobial strategies in light of pharmaceutical industry shifts.

Main Methods:

• Review of current literature on antibiotic resistance trends.
• Analysis of genetic mechanisms of resistance in gram-positive and gram-negative pathogens.
• Examination of the impact of specific strains like Staphylococcus aureus USA300 and gram-negative bacteria (Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae).

Main Results:

• Multidrug-resistant (MDR) bacterial pathogens are prevalent in both community and hospital settings.
• Complex resistance phenotypes arise from gene inactivation, efflux pump upregulation, and acquisition of resistance genes on mobile genetic elements.
• Emergence of gram-negative pathogens resistant to nearly all available antimicrobials is a critical concern.

Conclusions:

• The rapid evolution of antibiotic resistance genes presents a formidable challenge to public health.
• There is a critical need for renewed focus on developing new anti-infective agents.
• Addressing the complex genetic basis of resistance is essential for effective therapeutic strategies.